CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 2 of 15

Osteoporosis International

Briefs 41–80 of 576 CurrentRheuma has covered from this journal, newest publication first

Latest from Osteoporosis International

All coverage, newest first

  1. Osteoporos Int

    Smartphone-based patient-reported outcome of acute phase reaction after zoledronic acid infusion and prediction algorithm: a multicenter, prospective cohort study

    Cohort studyOsteoporosis

  2. Osteoporos Int

    The cost-effectiveness of biosimilar denosumab in postmenopausal osteoporosis: implications of baseline fracture risk and drug price

    Cohort studyOsteoporosis

  3. Osteoporos Int

    Comparative efficacy of biosimilar denosumab and reference denosumab in treatment of postmenopausal osteoporosis: a systematic review and meta-analysis

    Meta-analysisOsteoporosis

  4. Osteoporos Int

    Manual chart review reveals bisphosphonate exposure misclassification in atypical femur fracture patients: auditing medical records in two international cohorts

    Cohort studyOsteoporosis

  5. Osteoporos Int

    Impact of serum 25-hydroxyvitamin D levels on fragility fractures in patients undergoing chronic hemodialysis

    Cohort studyOsteoporosis

  6. Osteoporos Int

    Three months of abaloparatide treatment rapidly improves bone formation and density: implications for orthopedic preoperative bone health optimization

    Secondary analysisOsteoporosis

  7. Osteoporos Int

    The role of income and educational level as risk factors for atypical femur fractures: A Nationwide Danish Case-Cohort Study with Blinded Radiographic Review

    Cohort studyOsteoporosis

  8. Osteoporos Int

    Side-to-side differences in hip bone mineral density and associated morphological factors

    Cross-sectional studyOsteoporosis

  9. Osteoporos Int

    Osteoporosis and post-fracture management in the primary care setting: a systematic review

    Meta-analysisOsteoporosis

  10. Osteoporos Int

    Dietary and supplemental calcium intake and bone changes during antiresorptive osteoporosis treatment in older women: a longitudinal observational study

    Cohort studyOsteoporosis

  11. Osteoporos Int

    Influence of bisphosphonate pretreatment on bone mineral density gains and fracture outcomes with teriparatide: A systematic review and meta-analysis

    Meta-analysisOsteoporosis

  12. Osteoporos Int

    Lower fall and femoral fracture risks with semaglutide and tirzepatide compared with DPP-4 inhibitors in older adults with type 2 diabetes

    Cohort studyOsteoporosis

  13. Osteoporos Int

    Romosozumab in severe postmenopausal osteoporosis—real-world data from 192 women

    Cohort studyOsteoporosis

  14. Osteoporos Int

    Association between myosteatosis and bone mineral density in postmenopausal women

    Cross-sectional studyOsteoporosis

  15. Osteoporos Int

    Preventing post-denosumab bone loss with zoledronate: a 2-year randomized trial in post-menopausal women without and with pre-exposure to bisphosphonates

    Randomized controlled trialOsteoporosis

  16. Osteoporos Int

    Revisiting the Osteoporosis Self-Assessment Tool (OST): evidence from a multi-cohort study in Asia supporting age-dependent thresholds

    Diagnostic or prognostic studyOsteoporosis

  17. Osteoporos Int

    Multimorbidity patterns among fragility fracture patients aged 50 + years in China and the US

    Cross-sectional studyOsteoporosis

  18. Osteoporos Int

    Weight changes after smoking cessation and the risk of hip fractures: a nationwide population-based cohort study

    Cohort studyOsteoporosis

  19. Osteoporos Int

    AI-derived bone mineral density from standard radiographs compared with DXA for fracture prediction in a 10-year real-world cohort study

    Cohort studyOsteoporosis

  20. Osteoporos Int

    Romosozumab does not improve volumetric bone mineral density at distal radius but is associated with early changes in bone strength: a prospective study

    Cohort studyOsteoporosis

  21. Osteoporos Int

    Risk of medication-related osteonecrosis of the jaw during romosozumab treatment

    Cohort studyOsteoporosis

  22. Osteoporos Int

    Efficacy of romosozumab followed by denosumab in glucocorticoid users; a randomized clinical trial

    Randomized controlled trialOsteoporosis

  23. Osteoporos Int

    Association between vestibular dysfunction and osteoporosis in adults: a systematic review and meta-analysis

    Meta-analysisOsteoporosis

  24. Osteoporos Int

    Pre-teriparatide anti-osteoporosis medication therapy and fracture-related hospitalization in patients at very high fracture risk

    Cohort studyOsteoporosis

  25. Osteoporos Int

    “Don’t tell me I’m going to feel joy”: The emotional burden of informal caregivers of patients with a fragility fracture discharged from a rehabilitation hospital

    Research articleOsteoporosis

  26. Osteoporos Int

    Diabetes progression and its association with fracture risk in type 2 diabetes

    Cohort studyOsteoporosis

  27. Osteoporos Int

    Efficacy of denosumab versus zoledronate on preventing secondary osteoporotic vertebral compression fracture: a prospective study with 2-year follow-up

    Randomized controlled trialOsteoporosis

  28. Osteoporos Int

    Bone densitometry findings and prevalence of osteoporosis at initial scanning in girls with anorexia nervosa

    Cohort studyPediatric

  29. Osteoporos Int

    Consensus statement on the application of artificial intelligence in osteoporosis screening and management: perspectives from the Asia-Pacific region

    Guideline or statementOsteoporosis

  30. Osteoporos Int

    Vertebral fractures identified on lateral DXA images by deep learning predict incident fractures in older women

    Cohort studyOsteoporosis

  31. Osteoporos Int

    Postpartum timing of teriparatide initiation and BMD response in pregnancy- and lactation-associated osteoporosis: an observational study

    Cohort studyOsteoporosis

  32. Osteoporos Int

    Increased fracture risk associated with iron-deficiency anemia: a population-based propensity score matched cohort study

    Cohort studyOsteoporosis

  33. Osteoporos Int

    Fragility fractures of the pelvis and long-term outcomes among older adults with osteoporosis: a real-world cohort study

    Cohort studyOsteoporosis

  34. Osteoporos Int

    Effectiveness and safety of physical exercise and health education for the management of osteoporotic vertebral fractures: a systematic review and meta-analysis

    Meta-analysisOsteoporosis

  35. Osteoporos Int

    Impact of oral glucocorticoids on the effectiveness of romosozumab: the multicenter OASIS cohort study

    Cohort studyOsteoporosis

  36. Osteoporos Int

    Risk of fracture among patients with rheumatoid arthritis according to serological status: a population-based retrospective cohort study

    Cohort studyRA

  37. Osteoporos Int

    Mortality in patients over 65 with proximal humerus fractures: a systematic review of 414,379 shoulders with meta-analysis

    Meta-analysisOsteoporosis

  38. Osteoporos Int

    Forearm BMD predicts fracture independently of FRAX

    Meta-analysisOsteoporosis

  39. Osteoporos Int

    Revised Swedish FRAX models and the establishment of age-dependent intervention thresholds

    Cohort studyOsteoporosis

  40. Osteoporos Int

    Parathyroid hormone and alkaline phosphatase are associated with fracture risk in non-dialysis-dependent chronic kidney disease

    Cohort studyOsteoporosis

All 576 Briefs in ExploreShowing Briefs 41–80 of 576, newest first